Different methods of disseminating practice guidelines for children with croup

ISRCTN ISRCTN73394937
DOI https://doi.org/10.1186/ISRCTN73394937
ClinicalTrials.gov number NCT00147849
Secondary identifying numbers MCT-63141
Submission date
05/09/2005
Registration date
05/09/2005
Last edited
28/01/2019
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr David Wyatt Johnson
Scientific

Alberta Children's Hospital
Room 1562
1820 Richmond Road SW
Calgary
T2T 5C7
Canada

Phone +1 403 943 7507
Email david.johnson@calgaryhealthregion.ca

Study information

Study designCluster controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleA cluster controlled trial comparing three methods of disseminating practice guidelines for children with croup
Study acronymCPG
Study objectivesTo determine which of the three intervention strategies are most effective at lowering the rate of hospital days per 1000 disease episodes. To determine which of the three dissemination strategies are most effective at increasing the use of therapies of known benefit.
Ethics approval(s)University of Calgary Health Research Ethics Board approved on the 7th December 2000
Health condition(s) or problem(s) studiedCroup
InterventionGroup 1: Mailing of printed educational materials (the 'Standard intervention')
Group 2: Mailing plus a combination of interactive educational meetings, educational outreach visits, and reminders (a 'Saturn intervention')
Group 3: A combination of mailing, interactive sessions, outreach visits, reminders plus identification of local opinion leaders and establishment of local consensus processes (a 'Cadillac intervention')
Intervention typeOther
Primary outcome measureThe rate of hospital days per 1000 disease episodes.
Secondary outcome measures1. Proportion of patients treated in the Emergency Department (ED) and hospital with a corticosteroid
2. Proportion of patients evaluated in ED for at least 3 hours after treatment with corticosteroids before the decision to admit to hospital is made
3. Time to treatment with corticosteroids in both ED and hospital patients
Overall study start date01/12/2001
Completion date31/03/2006

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit28 Days
Upper age limit9 Years
SexBoth
Target number of participants24
Key inclusion criteria1. Alberta hospitals were rank ordered based on their rate of hospitalisation and the size of their patient population. The administrative, nursing, and medical staff from the 36 highest ranking hospitals were approached and asked to participate. 24 agreed and 12 refused
2. Children with croup aged 28 days to 9 years, either sex were the subject of the disseminated guidelines
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/12/2001
Date of final enrolment31/03/2006

Locations

Countries of recruitment

  • Canada

Study participating centre

Alberta Children's Hospital
Calgary
T2T 5C7
Canada

Sponsor information

Alberta Children's Hospital (Canada)
Hospital/treatment centre

1820 Richmond Road S.W.
Calgary
T2T 5C7
Canada

Phone +1 403 229 7211
Email david.johnson@calgaryhealthregion.ca
Website http://www.childrenshospital.ab.ca/albertachildrenshospital.html
ROR logo "ROR" https://ror.org/00sx29x36

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-63141)

No information available

Alberta Medical Association Medical Services Budget Innovation Fund (Canada)

No information available

Alberta Medical Association Clinical Practice Guideline Program (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 28/04/2006 Yes No

Editorial Notes

28/01/2019: Clinicaltrials.gov stated that this trial was terminated by November 2005